Education
About Us
Working with TipRanks
Follow Us
Cresco Labs OTC (TSE:CL)
:CL
CL Stock Chart & Stats
C$1.65
-C$0.07(-4.76%)
At close: 4:00 PM EST
C$1.65
-C$0.07(-4.76%)
Day’s Range― - ―
52-Week RangeC$0.60 - C$2.40
Previous CloseN/A
Volume48.59K
Average Volume (3M)315.07K
Market Cap
C$764.06M
Enterprise ValueC$790.51M
Total Cash (Recent Filing)C$146.61M
Total Debt (Recent Filing)C$630.91M
Price to Earnings (P/E)―
Beta2.37
Next Earnings
Nov 07, 2025EPS Estimate
-0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding338,757,080
10 Day Avg. Volume260,694
30 Day Avg. Volume315,069
Financial Highlights & Ratios
PEG Ratio0.07
Price to Book (P/B)0.66
Price to Sales (P/S)0.43
P/FCF Ratio2.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$2.18Price Target Upside32.41% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Bulls Say, Bears Say
Bulls Say
Cash FlowCresco generated positive operating cash flow of $30.5M in the quarter and finished the period with its highest cash balance in three years.
Financial PerformanceCresco Labs reported better than expected gross margins and cost containment, delivering EBITDA above forecast.
Bears Say
Revenue DeclineRevenue of $163.6M was down 1.3% sequentially and down 11.2% year-over-year.
System Conversion ImpactManagement cited the Illinois seed to sale system conversion will cause revenues to decrease slightly.
Cresco Labs News
CL FAQ
What was Cresco Labs OTC’s price range in the past 12 months?
Cresco Labs OTC lowest stock price was C$0.60 and its highest was C$2.40 in the past 12 months.
What is Cresco Labs OTC’s market cap?
Cresco Labs OTC’s market cap is C$764.06M.
When is Cresco Labs OTC’s upcoming earnings report date?
Cresco Labs OTC’s upcoming earnings report date is Nov 07, 2025 which is in 16 days.
How were Cresco Labs OTC’s earnings last quarter?
Cresco Labs OTC released its earnings results on Aug 07, 2025. The company reported -C$0.056 earnings per share for the quarter, missing the consensus estimate of -C$0.049 by -C$0.007.
Is Cresco Labs OTC overvalued?
According to Wall Street analysts Cresco Labs OTC’s price is currently Undervalued.
Does Cresco Labs OTC pay dividends?
Cresco Labs OTC does not currently pay dividends.
What is Cresco Labs OTC’s EPS estimate?
Cresco Labs OTC’s EPS estimate is -0.04.
How many shares outstanding does Cresco Labs OTC have?
Cresco Labs OTC has 338,757,080 shares outstanding.
What happened to Cresco Labs OTC’s price movement after its last earnings report?
Cresco Labs OTC reported an EPS of -C$0.056 in its last earnings report, missing expectations of -C$0.049. Following the earnings report the stock price went up 3.226%.
Which hedge fund is a major shareholder of Cresco Labs OTC?
Currently, no hedge funds are holding shares in TSE:CL
Cresco Labs Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$2.18 (32.41% Upside)
C$2.18 (32.41% Upside)
Blogger Sentiment
Bullish
TSE:CL Sentiment 70%
Sector Average 69%
Sector Average 69%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 4.8%
Last 30 Days ▼ 4.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-22.01%
12-Months-Change
Fundamentals
Return on Equity
-10.02%
Trailing 12-Months
Asset Growth
-0.76%
Trailing 12-Months
Company Description
Cresco Labs OTC
Cresco Labs (CL) is a prominent player in the cannabis industry, primarily focused on the cultivation, manufacturing, and distribution of cannabis products across the United States. The company operates in several key sectors, including retail, wholesale, and product innovation, offering a wide range of products such as flower, edibles, oils, and topicals through its various branded lines. Cresco Labs aims to enhance the cannabis experience for consumers while promoting responsible use and compliance with regulatory standards.
CL Company Deck
CL Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Cresco Labs demonstrated strong operational performance and strategic foresight with key achievements in debt refinancing and market share maintenance. However, challenges such as revenue decline and price compression persist. The company is focusing on sustainable growth and profitability amidst industry-wide consolidation pressures.View all TSE:CL earnings summariesCL Stock 12 Month Forecast
Average Price Target
C$2.18
▲(32.41% Upside)
Technical Analysis
Cronos Group
―
Curaleaf Holdings
―
Green Thumb Industries
―
Trulieve Cannabis
―
Verano Holdings
―
Options Prices
Currently, No data available
---